Archives
-
Cisplatin: Linking Efficacy to Kidney Toxicity
2026-08-30
Cisplatin, also known as CDDP, is more than a DNA-damaging chemotherapy model. This guide presents a paired assay framework that connects tumor-cell apoptosis and resistance with cisplatin-induced renal injury and Nrf2 pathway biology.
-
Single-Cell Basis of Ciprofloxacin-Tetracycline Antagonism
2026-08-29
Broughton, Fraisse, and El Karoui used microfluidics to show that tetracycline weakens ciprofloxacin activity primarily by increasing bacterial survival, rather than simply slowing population growth. The study links nutrient-dependent antagonism to distinct low- and high-SOS subpopulations, demonstrating why single-cell measurements are essential for interpreting antibiotic combinations.
-
Optimized hiPSC Platelet Production: Methods and Findings
2026-08-28
A 2026 study developed an optimized differentiation scheme for generating megakaryocytes and functional platelets from human induced pluripotent stem cells. By increasing embryoid body input, refining serum-free culture with human platelet lysate, replacing selected cytokines with small molecules, and promoting megakaryocyte maturation, the protocol shortened production time, increased yield, and reduced reported costs.
-
EGF-Driven A549 Migration Without EMT or Invasion
2026-08-28
The reference study separates EGF-driven migration from epithelial–mesenchymal transition and matrix invasion in A549 lung adenocarcinoma cells. Its comparison with TGFβ shows that similar migratory outcomes can arise through different pathway dependencies, highlighting why migration and invasion should be measured as distinct phenotypes.
-
Cisplatin Beyond Tumor Killing: Ovarian Models
2026-08-27
Cisplatin (CDDP) is more than a DNA-damaging anticancer compound: it is also a powerful model of ovarian injury and follicle apoptosis. This guide connects molecular damage, multi-omics evidence, and practical assay design for cancer research and reproductive-toxicity studies.
-
LDH Cytotoxicity Assay Kit for Cell Damage
2026-08-27
Turn membrane damage into a quantitative, non-radioactive readout for screening cells, treatments, and magnetic nanocomposites. This workflow emphasizes controls, interference testing, and practical interpretation so cell cytotoxicity measurement remains reliable across cancer research and biomaterial studies.
-
Nitrocefin: From Resistance Signal to Translational Strategy
2026-08-26
Nitrocefin is more than a rapid colorimetric reagent: it is a mechanistic bridge between β-lactamase biology, inhibitor discovery, and translational antibiotic resistance research. This article explains how its yellow-to-red signal can support biochemical validation of computationally identified peptide inhibitors, while clarifying assay controls, workflow limitations, and decision points for researchers moving from purified enzymes to complex biological systems.
-
KLF7–ITGA2 Axis in Oral Cancer Stemness
2026-08-26
This preprint identifies ITGA2 as a transcriptional and functional effector of KLF7-driven oral cancer stemness. Its combination of ITGA2–collagen blockade with cisplatin suggests a rational strategy for weakening cancer stem cell phenotypes and improving treatment response in oral squamous cell carcinoma models.
-
Spatially Concentrated ABEs for PLP1 Correction
2026-08-25
A 2026 Nucleic Acids Research study introduces spatially concentrated adenine base editors that improve PLP1 mutation correction in oligodendrocytes by enriching TadA* at nuclear target sites. The approach combines multivalent recruitment, a compact Cas9 variant, and functional myelination readouts, providing a mechanistic framework for editing difficult neural cell types while limiting transcriptome-wide RNA off-target effects.
-
IPR-803: Translational Leverage in uPAR Biology
2026-08-25
IPR-803 provides a mechanistically focused way to interrogate the uPAR–uPA interface across tumor invasion, metastasis, angiogenesis, and stromal biology. This thought-leadership analysis connects biochemical evidence with assay design, model selection, exposure strategy, and translational decision-making.
-
Fluorescein TSA Fluorescence System Kit Workflow
2026-08-24
Build a sensitive, spatially resolved workflow for rare proteins, transcripts, and signaling states in fixed cells and tissues. This practical guide shows how the Fluorescein TSA Fluorescence System Kit can extend IHC, ICC, and ISH beyond conventional fluorescence while controlling background and overamplification.
-
HBsAg–TBK1 Crosstalk in HBV Immune Evasion
2026-08-24
The reference study identifies a selective redirection of TBK1 signaling by hepatitis B surface antigen (HBsAg): TBK1 dimerization and phosphorylation increase, while TBK1–IRF3 coupling and type I interferon production decline. This mechanism links innate immune suppression with incomplete autophagy and HBV replication, providing a framework for interpreting TBK1-directed pharmacology in HBV research.
-
10058-F4 and TERT: Reading c-Myc Dependency
2026-08-23
10058-F4, a c-Myc-Max dimerization inhibitor, provides a focused way to connect transcription-factor disruption with TERT chromatin regulation. This article translates recent stem-cell findings into practical assay decisions for apoptosis, leukemia, and prostate cancer studies.
-
Pheromone-Driven Neurodegeneration in C. elegans
2026-08-22
The reference study shows that pheromone exposure during the C. elegans L1 stage can reprogram neural development and accelerate neurodegeneration in adulthood. Its central advance is a mechanistic link from ASK and ASI chemosensory neurons, through AIA interneurons and NLP-1 signaling, to insulin-like signaling and reduced neuronal autophagy.
-
FPR2/ALX Restricts Autoimmune Astrocytopathy
2026-08-22
The reference study shows that activating FPR2/ALX with Quin-C1 limits AQP4-IgG- and complement-associated astrocyte injury in mice by reshaping microglial and natural killer cell responses. Depletion and pathway-inhibition experiments position microglia, NK cells, and SYK-AKT signaling as important components of this protective response, while also defining the limits of current mechanistic interpretation.